Results 131 to 140 of about 10,879 (181)

cDNA 微阵列和组织微阵列对卵巢上皮性肿瘤基因的表达

Zhongshan Daxue xuebao. Yixue kexue ban, 2004
【目的】结合cDNA微阵列和RNA与冰冻组织微阵列原位杂交的方法以寻找新的特异性卵巢癌候选癌基因,为卵巢癌的早期诊断和治疗提供理论依据。【方法】利用cDNA微阵列筛选在所有3种上皮性卵巢肿瘤中(卵巢浆液性交界性肿瘤、卵巢浆液性腺癌和卵巢子宫内膜样腺癌)显示有意义表达的基因,由RNA与冰冻组织微阵列原位杂交证实其结果。【结果】28个基因在>70%卵巢肿瘤中显示出高表达,18个基因在>70%卵巢肿瘤中低表达;干扰素诱导的转膜蛋白1(IITP1)被进一步用于RNA与冰冻组织微阵列原位杂交研究 ...
doaj  

[He<b>'</b>s Yangchao recipe ameliorates premature ovarian insuffi-ciency by regulating 8-oxoguanine DNA glycosylase 1 in mice]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Hu R, Zhao Y, Wu Y, Zhang Y, Liu Q, Lin F, Zhang Q, Miao C.   +7 more
europepmc   +1 more source

A multi-constraint representation learning model for identification of ovarian cancer with missing laboratory indicators. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Lu Z, Huang F, Cai G, Liu J, Zhen X.
europepmc   +1 more source

Research progress in the treatment of partial platinum-sensitive recurrent ovarian cancer. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2021
Zhu M, Wang J, Wuna Y, Wang Y, Li H.
europepmc   +1 more source

Single-cell transcriptomics reveals tumor landscape in ovarian carcinosarcoma. [PDF]

J Zhejiang Univ Sci B
Xu J, Tu M.
europepmc   +1 more source

[MiR-4772 modulates tumor immune microenvironment by regulating immune- related genes in ovarian cancer]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao, 2022
Zhao A, Su Y, Fu D.
europepmc   +1 more source

[WW domain-containing ubiquitin E3 ligase 1 regulates immune infiltration in tumor microenvironment of ovarian cancer]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Guo X, DU R, Chen L, Guo K, Zhou B, Bian H, Han L.   +6 more
europepmc   +1 more source

[<i>Lichong Xiaozheng</i> Granules enhances cisplatin sensitivity of ovarian cancer xenografts in rats by regulating adenine nucleotide translocator 3-mediated mitochondrial apoptosis]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Chen Y, Ma M, Su R, Zhu Y, Feng Q, Luo J, Feng W, Yan X.   +7 more
europepmc   +1 more source

[MiR-125b-5 suppresses ovarian cancer cell migration and invasion by targeted downregulation of CD147]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao, 2022
Huang Z, Shen H, Deng H, Sun L, Qü B.
europepmc   +1 more source

Research progress in lncRNA and its action as ceRNA in ovarian function as well as the relevant diseases. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2021
Li Y, Chen J, Luo Q, Tan Y.
europepmc   +1 more source